FDA Inspection 900831 — Halogent, LLC

Halogent, LLC — FEI 3010167044

The FDA completed an inspection of Halogent, LLC on September 23, 2014 in Seattle, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 23, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Seattle, WA (United States)